Power Law company profile

Dicerna Pharmaceuticals

Biotech & Life Sciences · Watertown, United States · Founded 2007 · IPO 2014 Unicorn

Delivering RNAi-based breakthrough therapies to improve lives

Valuation

$3.30B

Market cap · 2026

Revenue

$191M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

11 investors on Dicerna Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage

Kyowa Kirin

Skyline Ventures

Abingworth

Oxford Bioscience Partners

Series B+ 7 investors entered at this stage

RA Capital Management

Domain Associates

HealthCare Ventures

Deerfield Partners

Omega Funds

Brookside Capital

SR One

Global footprint

Where Dicerna Pharmaceuticals has talent and traffic

Workforce by country

1 countries with
team presence

🇺🇸 United States98.3%

1 country shown

Patent intelligence

$97M patent portfolio · 85 active families

Estimated portfolio value

$97M

3.0% of market cap · 8× smaller than top peer BioNTech ($780M)

85 active patent families

Where Dicerna Pharmaceuticals innovates Molecular biologyOligonucleotideCell biologyDicerBiochemistry

Where Dicerna Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Dicerna Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Dicerna Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Dicerna Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Dicerna Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles